Aegerion Pharmaceuticals, Inc. Expands Commercial Leadership With Rare Disease Experience

CAMBRIDGE, Mass., July 27, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced the appointment of Paul J. Merrigan as Vice President of Global Marketing.
MORE ON THIS TOPIC